Literature DB >> 23432381

A comprehensive review on SAR of curcumin.

A Rajasekhar Reddy1, P Dinesh, A S Prabhakar, K Umasankar, B Shireesha, M Bhagavan Raju.   

Abstract

Curcumin, a natural diaryl heptanoid continues to be used as an alternative medicinal agent in many parts of South East Asia for treatment of many ailments. It can be usually obtained from substituted aryl aldehydes and acetylacetone and this route enables synthesis of a diverse set of curcumin analogues. Numerous analogues have been synthesized and tested by several researchers to investigate their activity against known biological targets and to improve upon the pharmacological and ADME profile by modifying substitutions on aromatic rings, β-diketone moiety and two flanking double bonds conjugated to the β-diketone moiety. Successful synthesis of such derivatives with modifications has resulted in the development of potential anticancer candidates that target various stages in cancer cell growth and development. Based on the evidences in modifications of these three functional elements, we have attempted to summarize the structure activity relationship of molecules which can be further utilized by researchers in medicinal chemistry in exploring the structure of curcumin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23432381     DOI: 10.2174/1389557511313120007

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  9 in total

1.  A Realistic View on "The Essential Medicinal Chemistry of Curcumin".

Authors:  Fatemeh Bahadori; Mutlu Demiray
Journal:  ACS Med Chem Lett       Date:  2017-09-14       Impact factor: 4.345

Review 2.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 3.  A Review on Mechanistic Insight of Plant Derived Anticancer Bioactive Phytocompounds and Their Structure Activity Relationship.

Authors:  Kishor Mazumder; Asma Aktar; Priyanka Roy; Biswajit Biswas; Md Emran Hossain; Kishore Kumar Sarkar; Sitesh Chandra Bachar; Firoj Ahmed; A S M Monjur-Al-Hossain; Koichi Fukase
Journal:  Molecules       Date:  2022-05-09       Impact factor: 4.927

4.  Synthesis of Novel Aza-aromatic Curcuminoids with Improved Biological Activities towards Various Cancer Cell Lines.

Authors:  Atiruj Theppawong; Tim Van de Walle; Charlotte Grootaert; Margot Bultinck; Tom Desmet; John Van Camp; Matthias D'hooghe
Journal:  ChemistryOpen       Date:  2018-05-25       Impact factor: 2.911

Review 5.  Hybrid curcumin compounds: a new strategy for cancer treatment.

Authors:  Marie-Hélène Teiten; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2014-12-12       Impact factor: 4.411

6.  Synthesis of nano-fibers containing nano-curcumin in zein corn protein and its physicochemical and biological characteristics.

Authors:  Narges Fereydouni; Jebrail Movaffagh; Nafise Amiri; Susan Darroudi; Aida Gholoobi; Arash Goodarzi; Alireza Hashemzadeh; Majid Darroudi
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

7.  Molecular modeling piloted analysis for semicarbazone derivative of curcumin as a potent Abl-kinase inhibitor targeting colon cancer.

Authors:  Fiona C Rodrigues; Gangadhar Hari; K S R Pai; Akhil Suresh; Usha Y Nayak; N V Anilkumar; Goutam Thakur
Journal:  3 Biotech       Date:  2021-11-22       Impact factor: 2.406

8.  Design, Synthesis, and Antitumor Evaluation of Novel Mono-Carbonyl Curcumin Analogs in Hepatocellular Carcinoma Cell.

Authors:  Pan Yu; Weiya Cao; Linguo Zhao; Qing Han; Shilong Yang; Kepeng Yang; Xiaolei Pan; Qianyun Wang; Yuan Wang
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-30

9.  Curcumin Conjugates of Non-steroidal Anti-Inflammatory Drugs: Synthesis, Structures, Anti-proliferative Assays, Computational Docking, and Inflammatory Response.

Authors:  Kenneth K Laali; Angela T Zwarycz; Nicholas Beck; Gabriela L Borosky; Manabu Nukaya; Gregory D Kennedy
Journal:  ChemistryOpen       Date:  2020-08-13       Impact factor: 2.911

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.